Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

article









Bertina, R.M.

Tilburg, N.H. van

Haverkate, F.

Bouma, B.N.

Borne, P.A.K. von dem

Meijers, J.C.M.

Campbell, W.

Eaton, D.

Hendriks, D.F.

Willemse, J.L.
CAS: blood clotting factor 11, 9013-55-2; thrombin, 9002-04-4; tissue plasminogen activator, 105913-11-9; protein C, 60202-16-6; Carboxypeptidase U, 3.4.17.20; Protein C; Tissue Plasminogen Activator, 3.4.21.68
Topics






























Biomedical Researchblood clotting factor 11thrombinthrombin activatable fibrinolysis inhibitortissue plasminogen activatorprotein Carticlebleeding tendencyblood clot lysisblood clottingblood clotting factor 11 deficiencyenzyme activityfibrinolysishumanlaboratorymethodologynonhumanpriority journalthrombogenesisthrombosisdrug antagonismhistorynotephysiologyCarboxypeptidase UFibrinolysisHistory, 20th CenturyHistory, 21st CenturyHumansProtein CTissue Plasminogen Activator
TNO Identifier
239057
Repository link
https://resolver.tno.nl/uuid:108c2b12-47a7-4483-98e1-50ba200d36a4
ISSN
15387933
Source
Journal of Thrombosis and Haemostasis, 4(1), pp. 256-262.
Pages
256-262
Files
To receive the publication files, please send an e-mail request to TNO Repository.